Please login to the form below

Not currently logged in


This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

Antiviral drug initially scored emergency use authorisation in May. The US Food and Drug Administration (FDA) has approved Gilead’s remdesivir – now Veklury – for the treatment of hospitalised COVID-19 patients. ... In addition to the results from

Latest news

More from news
Approximately 705 fully matching, plus 2,783 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 147 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 48 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...